ALT Historical PE Ratio image   This ALT PE ratio history page last updated 11/14/2022
ALT Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/10/2022
10.58-0.48-1.92NA
Q2 2022
8/11/2022
13.77-0.42-1.68NA
Q1 2022
5/12/2022
4.28-0.44-1.76NA
Q4 2021
3/15/2022
5.90-0.57-2.28NA
Q3 2021
11/9/2021
10.92-0.81-3.24NA
Q2 2021
8/10/2021
10.88-0.41-1.64NA
Q1 2021
5/17/2021
14.18-0.38-1.52NA
Q4 2020
2/25/2021
17.20-0.17-0.68NA
Q3 2020
11/9/2020
7.83-0.54-2.16NA
Q2 2020
8/11/2020
23.10-0.94-3.76NA
Q1 2020
5/13/2020
4.13-0.26-1.04NA
Q4 2019
3/27/2020
2.85-0.25-1.00NA
Q3 2019
11/13/2019
1.76-0.74-2.96NA
Q2 2019
8/13/2019
2.12-0.26-1.04NA
Q1 2019
5/14/2019
2.63-0.27-1.08NA
Q4 2018
4/1/2019
3.25-0.02-0.08NA
Q3 2018
11/13/2018
3.40-1.73-6.92NA
Q2 2018
8/14/2018
10.80-0.34-1.36NA
Q1 2018
5/15/2018
16.02-0.23-0.92NA
Q4 2017
3/28/2018
33.00-0.08-0.32NA
ALT PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/10/2022
10.58-0.48-1.91NA
Q2 2022
8/11/2022
13.77-0.42-2.24NA
Q1 2022
5/12/2022
4.28-0.44-2.23NA
Q4 2021
3/15/2022
5.90-0.57-2.17NA
Q3 2021
11/9/2021
10.92-0.81-1.60NA
Q2 2021
8/10/2021
10.88-0.41-0.96NA
Q1 2021
5/17/2021
14.18-0.38-1.09NA
Q4 2020
2/25/2021
17.20-0.17-1.91NA
Q3 2020
11/9/2020
7.83-0.54-1.99NA
Q2 2020
8/11/2020
23.10-0.94-2.19NA
Q1 2020
5/13/2020
4.13-0.26-1.51NA
Q4 2019
3/27/2020
2.85-0.25-1.52NA
Q3 2019
11/13/2019
1.76-0.74-1.29NA
Q2 2019
8/13/2019
2.12-0.26-2.28NA
Q1 2019
5/14/2019
2.63-0.27-2.36NA
Q4 2018
4/1/2019
3.25-0.02-2.32NA
Q3 2018
11/13/2018
3.40-1.73-2.38NA
Q2 2018
8/14/2018
10.80-0.34NANA
Q1 2018
5/15/2018
16.02-0.23NANA
Q4 2017
3/28/2018
33.00-0.08NANA
Quotes delayed 20 minutes

Email EnvelopeFree ALT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Altimmune (ALT) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ALVR PE Ratio History
ALXN PE Ratio History
ALXO PE Ratio History
ALZN PE Ratio History
AMED PE Ratio History
AMEH PE Ratio History
AMGN PE Ratio History
AMN PE Ratio History
AMPH PE Ratio History
AMRX PE Ratio History
How should the ALT historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Altimmune. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this ALT Historical PE Ratio page.

What is the average historical PE for ALT based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The ALT historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for ALT based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The ALT historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the ALT Historical PE Ratio information for Altimmune' stock. The average ALT historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ALT historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ALT historical PE result, against the recent PE: when this page was posted on 11/11/2022, the most recent closing price for ALT had been 10.69, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on ALT or any other given stock, valuation analysis for ALT can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Altimmune PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ALT. Thanks for visiting, and the next time you need to research ALT Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Funds Holding BAOS, AEYE shares outstanding history, PG&E 13F Filers.

 

ALT Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.